Skip to content

600079.SH

ST人福

SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

CNY 17.85
−0.22%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue23.9B24.0B25.4B24.5B22.3B
Cost of Revenue12.3B12.4B14.1B13.3B12.6B
Gross Profit11.6B11.6B11.3B11.2B9.7B
Operating Expenses
R&D Expense1.5B1.5B1.5B1.5B966.9M
SG&A Expense
General & Admin Expense1.7B1.7B1.9B1.8B1.6B
Selling & Marketing Expense4.5B4.5B4.6B4.4B4.3B
Other Expenses
Total Operating Expenses8.2B8.2B8.6B8.1B7.2B
Cost and Expenses20.5B20.6B22.7B21.4B19.9B
Operating Income (EBIT)3.3B3.2B2.5B3.4B3.5B
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)3.2B3.1B2.4B3.4B3.4B
Income Tax Expense605.3M564.0M644.5M568.6M354.8M
Bottom Line
Net Income1.9B1.9B1.3B2.1B2.5B
Earnings from Cont. Ops2.6B2.5B1.8B2.8B3.1B
Earnings from Discont. Ops
Bottom Line Net Income1.9B1.9B1.3B2.1B2.5B
Per Share
Basic EPSCN¥1.17CN¥1.14CN¥0.82CN¥1.32CN¥1.54
Diluted EPSCN¥1.17CN¥1.14CN¥0.82CN¥1.31CN¥1.54
Revenue Per ShareCN¥14.64CN¥14.72CN¥15.69CN¥15.17CN¥13.85
Shares
Basic Shares Outstanding1.6B1.6B1.6B1.6B1.6B
Diluted Shares Outstanding1.6B1.6B1.6B1.6B1.6B
Profitability Metrics
EBITDA4.2B3.5B4.2B4.3B
D&A1.0B1.0B802.2M738.3M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026